Mohammed Tikly

Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

A. J. Tyndall, Bettina Bannert, M.J. Vonk et al. · Annals of the Rheumatic Diseases · 2010 · 1.4K citations

Mapping and predicting mortality from systemic sclerosis

Muriel Elhaï, Christophe Meune, Marouane Boubaya et al. · Annals of the Rheumatic Diseases · 2017 · 642 citations · Full text

A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis

Paul Emery, FC Breedveld, E.‐M. Lemmel et al. · Lara D. Veeken · 2000 · 469 citations

Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study

Veronika K. Jaeger, Elina G. Wirz, Yannick Allanore et al. · PLoS ONE · 2016 · 264 citations · Full text

IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus

Timothy B. Niewold, Jennifer A. Kelly, Silvia N. Kariuki et al. · Annals of the Rheumatic Diseases · 2011 · 143 citations · Full text